Société commerciale d' Importation, d' Exportation et de Transport de Médicaments
0828.910.827 · rovalta.com · 28/09/2026
ACTIVE
Société commerciale d' Importation, d' Exportation et de Transport de Médicaments
Financial year 2024 · Closed on 31/12/2024
Net result14,5 k €+1 377,0 %over 1 year
Gross margin19,6 k €+540,0 %over 1 year
Equity124,9 k €+13,1 %over 1 year
Overview
Identity
Source · BCE/KBOSociété commerciale d' Importation, d' Exportation et de Transport de Médicaments is a Private company with limited liability incorporated in 2010. Its main activity is: Agents involved in the sale of furniture, household goods, hardware and ironmongery. Its registered office is in Ixelles.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0828.910.827
- Incorporation
- 31/08/2010
- Legal form
- Private company with limited liability
- Registered office
- Rue Francart 28
1050 Ixelles · BruxellesSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2024
Activities (NACE)
46150Agents involved in the sale of furniture, household goods, hardware and ironmongery· main46150Agents involved in the sale of furniture, household goods, hardware and ironmongery46460Wholesale of pharmaceutical goods46460Wholesale of pharmaceutical goods52250Support activities for transportation52290Other transportation support activities
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 15 filingsTrend over 15 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 19,6 k € | +540% | 3,1 k € | -70.8% | 10,5 k € | -55.1% | 23,4 k € | +28.4% | 18,2 k € |
| EBITDA | 19,2 k € | +847% | 2 k € | -80.5% | 10,4 k € | -53.4% | 22,3 k € | +27.9% | 17,4 k € |
| Operating result | 19,2 k € | +847% | 2 k € | -80.5% | 10,4 k € | -53.4% | 22,3 k € | +27.9% | 17,4 k € |
| Net result | 14,5 k € | +1377% | 979 € | -87.0% | 7,5 k € | -55.4% | 16,9 k € | +31.8% | 12,8 k € |
| Balance sheet | |||||||||
| Equity | 124,9 k € | +13.1% | 110,5 k € | +0.9% | 109,5 k € | +7.4% | 102 k € | +19.8% | 85,1 k € |
| Total assets | 230,3 k € | -26.2% | 312,1 k € | -4.6% | 327,2 k € | +20.5% | 271,5 k € | +48.1% | 183,3 k € |
| Cash | 16,4 k € | +100% | 8,2 k € | +56.9% | 5,2 k € | -52.3% | 10,9 k € | +152% | 4,3 k € |
| Debts | 105,4 k € | -47.7% | 201,6 k € | -7.4% | 217,7 k € | +28.4% | 169,6 k € | +72.6% | 98,3 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20241 active · 1 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Chantal KALUBI MATAMBA | Directorsince 05/10/2020 |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Nyindu MATAMBA | Manager01/09/2010 → 05/10/2020Mandate |
Other companies at this address
Rue Francart 28 1050 Ixelles| Company | CBE no. |
|---|---|
AFRICAN GENERAL TRADING● Bankrupt | 0461.324.872 |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/08/2025 | 28/09/2024 | 27/09/2023 | 31/08/2022 | 30/08/2021 | 30/10/2020 |
| General meeting | 11/04/2025 | 12/04/2024 | 14/04/2023 | 09/04/2022 | 09/04/2021 | 10/04/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 15 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2024 | 11/04/2025 | 31/08/2025 | French | |
| Micro model | 31/12/2023 | 12/04/2024 | 28/09/2024 | French | |
| Micro model | 31/12/2022 | 14/04/2023 | 27/09/2023 | French | |
| Micro model | 31/12/2021 | 09/04/2022 | 31/08/2022 | French | |
| Micro model | 31/12/2020 | 09/04/2021 | 30/08/2021 | French | |
| Micro model | 31/12/2019 | 10/04/2020 | 30/10/2020 | French | |
| Micro model | 31/12/2018 | 12/04/2019 | 30/08/2019 | French | |
| Micro model | 31/12/2017 | 13/04/2018 | 04/08/2018 | French | |
| Abridged model | 31/12/2016 | 14/04/2017 | 26/08/2017 | French | |
| Abridged model | 31/12/2015 | 08/04/2016 | 31/08/2016 | French | |
| Abridged model | 31/12/2014 | 10/04/2015 | 31/08/2015 | French | |
| Abridged model | 31/12/2013 | 11/04/2014 | 15/01/2015 | French | |
| Abridged model | 31/12/2012 | 10/05/2013 | 29/11/2013 | French | |
| Abridged model | 31/12/2011 | 13/04/2012 | 16/08/2012 | French | |
| Abridged model | 31/12/2010 | 08/04/2011 | 18/11/2011 | French |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active · 1 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Chantal KALUBI MATAMBA | Directorsince 05/10/2020 |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Nyindu MATAMBA | Manager01/09/2010 → 05/10/2020Mandate |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings15 filings
Mandates
Chantal KALUBI MATAMBA
Nyindu MATAMBA
20102011201220132014201520162017201820192020202120222023202420252026
Société commerciale d' Importation, d' Exportation et de Transport de Médicaments
Rue Francart 28, 1050 Ixelles
Director
Manager
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Rue Francart 28, 1050 IxellesCurrent | accounts 2021 → 2024 | Accounts 2024 · 2025-00478448 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Société commerciale d' Importation, d' Exportation et de Transport de MédicamentsCurrent | accounts 2021 → 2024 | Accounts 2024 · 2025-00478448 |
Events
- 2024Annual accounts 202414,5 k €↑
- 2023Annual accounts 2023979 €↓
- 2022Annual accounts 20227,5 k €↓
- 2021Annual accounts 202116,9 k €↑
- 2020Annual accounts 202012,8 k €↑
- 2019Annual accounts 20191,1 k €↓
- 2018Annual accounts 20187 k €↓
- 2017Annual accounts 201712 k €↑
- 2016Annual accounts 201610,8 k €↑
- 2015Annual accounts 20158,4 k €↑
- 2014Annual accounts 20146 k €↓
- 2013Annual accounts 20136,4 k €↑
- 2012Annual accounts 20121,2 k €↓
- 2011Annual accounts 20113,3 k €↑
- 2010Annual accounts 2010-1,2 k €
- 31/08/2010IncorporationPrivate company with limited liability